search
Back to results

Breathing Training for Asthma

Primary Purpose

ASTHMA

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Capnometry Assisted Respiration Training
Breathing Awareness
Sponsored by
Southern Methodist University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for ASTHMA focused on measuring Asthma, Dyspnea, Paroxysmal, Pulmonary, Respiratory hypersensitivity, Airway inflammation, Airway obstruction, Wheezing

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Men or women between 18 and 65 years of age
  2. Understand and read english adequately
  3. A previously documented history of asthma from intermittent to severe (symptoms plus objective documentation of at least partially reversible airflow obstruction)
  4. Willing to undergo a 5-session course of breathing training
  5. Current asthma symptoms

Exclusion Criteria:

  1. Clinically significant heart disease
  2. Clinically significant cerebrovascular disease
  3. Clinically significant thyroid dysfunction
  4. Out-of-control diabetes
  5. Use of oral corticosteroids in the last 3 months
  6. Active smokers or more than 10 pack years
  7. Clinically significant chronic obstructive pulmonary disease
  8. Clinically significant emphysema
  9. Current alcohol and substance dependence
  10. Psychotic disorders and high risk for personality disorders
  11. Having received previous breathing training exercises for asthma
  12. Not willing to abstain from taking the morning dose of their long-term bronchodilator or leukotriene inhibitors or from using their short-acting beta-2 adrenergic agonists or anticholinergic bronchodilators for 8 hours before the pre-treatment, post-treatment, 1-month follow-up, and 6-month follow-up assessments (Medication withdrawal will be discouraged if patients should experience significant symptoms before the assessments. They will be offered to reschedule the appointment without any consequences for their enrollment in the study.)
  13. Night shift workers
  14. Tuberculosis
  15. Pregnant, plan on becoming pregnant, or nursing during the course of the study

Sites / Locations

  • Baylor University Medical Center (BUMC)
  • Southern Methodist University (SMU)

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Breathing Training

Breathing Awareness

Arm Description

Patients will receive biofeedback assisted breathing training

Patients will receive biofeedback assisted breathing awareness training.

Outcomes

Primary Outcome Measures

pCO2 levels (as an indicator of training manipulation success)
diurnal PEF variability (as an indicator of asthma pathophysiology and control)
Asthma Control Test (as a self-report indicator of asthma control)

Secondary Outcome Measures

respiration rate from capnometry and further measures of ventilation from ambulatory recordings (as further indicators of training manipulation success)
FeNO
airway hyperreactivity by methacholine
spirometric lung function and respiratory resistance (as further indicators of asthma pathophysiology)
reported symptoms
monitored bronchodilator use
reported inhaled corticosteroid use (as self-report and behavioral indicators of asthma control)
effects on perceived general control of asthma management, asthma self-efficacy, and impact and control of asthma triggers (as an indicator of asthma self-management)
physical and mental health status, stress, anxiety and depression (as indicators of general well-being)

Full Information

First Posted
September 10, 2009
Last Updated
May 31, 2018
Sponsor
Southern Methodist University
Collaborators
National Heart, Lung, and Blood Institute (NHLBI), Baylor Health Care System
search

1. Study Identification

Unique Protocol Identification Number
NCT00975273
Brief Title
Breathing Training for Asthma
Official Title
Targeting CO2 Levels in Breathing Training for Asthma
Study Type
Interventional

2. Study Status

Record Verification Date
May 2018
Overall Recruitment Status
Completed
Study Start Date
July 2008 (undefined)
Primary Completion Date
July 2013 (Actual)
Study Completion Date
July 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Southern Methodist University
Collaborators
National Heart, Lung, and Blood Institute (NHLBI), Baylor Health Care System

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
For the proposed randomized controlled treatment study, the investigators plan to compare the effects of this hypoventilation-based breathing training with a control intervention that will focus on breathing regularity and awareness. The two therapeutic procedures are closely matched on important variables such as duration and the nature of patient-therapist interaction, monitoring asthma related status and the medication intake, use of scientific equipment and monitoring devices to increase adherence, and initial plausibility. Asthma patients who will be evaluated before, during, directly after, and at 2 months and 6 months after training.
Detailed Description
For this randomized controlled treatment study, the investigators plan to compare the effects of hypoventilation-based breathing training with a control intervention that will focus on breathing regularity and awareness. The two therapeutic procedures are closely matched on important variables such as duration and the nature of patient-therapist interaction, monitoring asthma related status and the medication intake, use of scientific equipment and monitoring devices to increase adherence, and initial plausibility. Asthma patients will be evaluated before, during, directly after, and at 1 month and 6 months after training. The primary goal of this training is to determine if a capnometry-assisted breathing training to raise end-tidal CO2 will produce more improvement in asthma control than a control training of breathing awareness. The second goal is to determine if capnometry-assisted breathing training for raising pCO2 will lead to higher pCO2 levels after training than before training on all three measures of pCO2 (the 2-hour monitoring, the standardized training sessions, and the homework assignments). The last objective is to determine if the clinical improvement in asthma outcomes for the raise-pCO2 breathing group will be greater in patients with more improvement in their pCO2.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
ASTHMA
Keywords
Asthma, Dyspnea, Paroxysmal, Pulmonary, Respiratory hypersensitivity, Airway inflammation, Airway obstruction, Wheezing

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
120 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Breathing Training
Arm Type
Experimental
Arm Description
Patients will receive biofeedback assisted breathing training
Arm Title
Breathing Awareness
Arm Type
Active Comparator
Arm Description
Patients will receive biofeedback assisted breathing awareness training.
Intervention Type
Behavioral
Intervention Name(s)
Capnometry Assisted Respiration Training
Other Intervention Name(s)
CART
Intervention Description
Patients learn to alter their breathing pattern by breathing abdominally, slowly, regularly, and shallowly in order to raise their PCO2 levels with the assistance of a biofeedback device.
Intervention Type
Behavioral
Intervention Name(s)
Breathing Awareness
Intervention Description
Patients learn to alter their breathing pattern by breathing abdominally, slowly, regularly using a biofeedback device.
Primary Outcome Measure Information:
Title
pCO2 levels (as an indicator of training manipulation success)
Time Frame
Measured at pre-treatment, post-treatment, 1-month follow-up, and 6-month follow-up, at the beginning of each of the five weekly training sessions, patients perform self-assessments on a daily basis throughout, pre- and post-treatment 2h monitoring
Title
diurnal PEF variability (as an indicator of asthma pathophysiology and control)
Time Frame
pre-treatment, post-treatment, 1-month follow-up, and 6-month follow-up
Title
Asthma Control Test (as a self-report indicator of asthma control)
Time Frame
Measured at pre-treatment, post-treatment, 1-month follow-up, and 6-month follow-up. Further assessments will be made at the beginning of each of the five weekly training sessions.
Secondary Outcome Measure Information:
Title
respiration rate from capnometry and further measures of ventilation from ambulatory recordings (as further indicators of training manipulation success)
Time Frame
Measured at pre-treatment, post-treatment, 1-month follow-up, and 6-month follow-up, at the beginning of each of the five weekly training sessions, patients perform self-assessments on a daily basis throughout, pre- and post-treatment 2h monitoring
Title
FeNO
Time Frame
Measured at pre-treatment, post-treatment, 1-month follow-up, and 6-month follow-up, at the beginning of each of the five weekly training sessions
Title
airway hyperreactivity by methacholine
Time Frame
at pretreatment and optionally at 1 month follow up
Title
spirometric lung function and respiratory resistance (as further indicators of asthma pathophysiology)
Time Frame
Measured at pre-treatment, post-treatment, 1-month follow-up, and 6-month follow-up, at the beginning of each of the five weekly training sessions, patients perform self-assessments on a daily basis throughout.
Title
reported symptoms
Time Frame
Measured at pre-treatment, post-treatment, 1-month follow-up, and 6-month follow-up, at the beginning of each of the five weekly training sessions, patients perform self-assessments on a daily basis throughout
Title
monitored bronchodilator use
Time Frame
Measured at pre-treatment, post-treatment, 1-month follow-up, and 6-month follow-up, at the beginning of each of the five weekly training sessions, patients record usage throughout treatment
Title
reported inhaled corticosteroid use (as self-report and behavioral indicators of asthma control)
Time Frame
Measured at pre-treatment, post-treatment, 1-month follow-up, and 6-month follow-up, at the beginning of each of the five weekly training sessions
Title
effects on perceived general control of asthma management, asthma self-efficacy, and impact and control of asthma triggers (as an indicator of asthma self-management)
Time Frame
Measured at pre-treatment, post-treatment, 1-month follow-up, and 6-month follow-up, at the beginning of each of the five weekly training sessions
Title
physical and mental health status, stress, anxiety and depression (as indicators of general well-being)
Time Frame
Measured at pre-treatment, post-treatment, 1-month follow-up, and 6-month follow-up, at the beginning of each of the five weekly training sessions

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Men or women between 18 and 65 years of age Understand and read english adequately A previously documented history of asthma from intermittent to severe (symptoms plus objective documentation of at least partially reversible airflow obstruction) Willing to undergo a 5-session course of breathing training Current asthma symptoms Exclusion Criteria: Clinically significant heart disease Clinically significant cerebrovascular disease Clinically significant thyroid dysfunction Out-of-control diabetes Use of oral corticosteroids in the last 3 months Active smokers or more than 10 pack years Clinically significant chronic obstructive pulmonary disease Clinically significant emphysema Current alcohol and substance dependence Psychotic disorders and high risk for personality disorders Having received previous breathing training exercises for asthma Not willing to abstain from taking the morning dose of their long-term bronchodilator or leukotriene inhibitors or from using their short-acting beta-2 adrenergic agonists or anticholinergic bronchodilators for 8 hours before the pre-treatment, post-treatment, 1-month follow-up, and 6-month follow-up assessments (Medication withdrawal will be discouraged if patients should experience significant symptoms before the assessments. They will be offered to reschedule the appointment without any consequences for their enrollment in the study.) Night shift workers Tuberculosis Pregnant, plan on becoming pregnant, or nursing during the course of the study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Alicia Meuret, PhD
Organizational Affiliation
SMU
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Thomas Ritz, PhD
Organizational Affiliation
SMU
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Mark Millard, MD
Organizational Affiliation
BUMC
Official's Role
Principal Investigator
Facility Information:
Facility Name
Baylor University Medical Center (BUMC)
City
Dallas
State/Province
Texas
ZIP/Postal Code
75204
Country
United States
Facility Name
Southern Methodist University (SMU)
City
Dallas
State/Province
Texas
ZIP/Postal Code
75275
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
25122497
Citation
Ritz T, Rosenfield D, Steele AM, Millard MW, Meuret AE. Controlling asthma by training of Capnometry-Assisted Hypoventilation (CATCH) vs slow breathing: a randomized controlled trial. Chest. 2014 Nov;146(5):1237-1247. doi: 10.1378/chest.14-0665.
Results Reference
derived

Learn more about this trial

Breathing Training for Asthma

We'll reach out to this number within 24 hrs